Expertise in Action: When Regulation Shapes Innovation from the Start

In Expertise in Action, ProductLife Group spotlights the people whose expertise helps turn complexity into progress across the life sciences lifecycle. For Pascale Cousin, that impact begins at one of the earliest and most decisive moments in innovation: defining the right regulatory path from the outset. 

In health innovation, the first challenge is not always scientific. Often, it is strategic. Before a product can move toward development, investment, or market access, companies need to understand what they are actually building from a regulatory perspective. Is it a medicinal product, a medical device, an in vitro diagnostic, or another regulated technology? The answer shapes everything that follows. 

As Medical Device Director, Pascale works with companies developing highly innovative health-related products, helping them navigate exactly this kind of decision. Her role is to bring structure and clarity when the regulatory landscape still feels abstract and the route to market is not yet fully defined. 

This is where her expertise creates particular value. Product classification is not a purely technical exercise. It determines evidence requirements, documentation, timelines, and the broader development strategy. Getting it right early helps clients move forward with a viable and realistic path, avoiding costly uncertainty later on. 

What makes this work especially meaningful is that it happens when ideas are still fragile. At this stage, clients often need more than technical guidance. They need a partner who can educate, reassure, and challenge them in equal measure, helping them understand the implications of each decision without losing confidence or momentum. 

Pascale brings both operational and strategic depth to this role. She leads activities in regulatory and quality compliance for medical devices and in vitro diagnostic devices, including implants, combination products, electromedical devices, and software. Her broader industry experience also gives her a clear understanding of business realities, enabling her to translate regulation into tailored, pragmatic solutions aligned with each client’s context. 

For Pascale, excellence in this field means helping clients access the market quickly while maintaining full regulatory compliance through a tailored approach. In practice, that means combining trust, technical rigor, co-construction, and agility in a fast-changing environment shaped by developments in artificial intelligence, cybersecurity, clinical evidence, and sustainability-related requirements. 

Her perspective also reflects something broader about PLG’s model. In a field as complex as medtech and health innovation, no single expert can cover every dimension alone. What makes the difference is the ability to connect specialist knowledge across disciplines and geographies, giving clients access to integrated expertise throughout the product lifecycle. 

Pascale’s approach ultimately challenges a common misconception: regulation is not simply a barrier to innovation. When understood early and approached strategically, it becomes the framework that allows innovation to move forward with clarity, confidence, and purpose. 

Let’s shape your regulatory pathway together. Contact us to get started: